This distinction is incredibly important because while many groups presume that the HER2 status of the brain metastasis is the same as the HER2 status of the primary breast neoplasm, this presumption is wrong in approximately 10%–15% of cases [10, 11, 12, 13, 14]. Here, ERBB2 is linked to breast neoplasm.